β3 Adrenergic Receptor Agonists for the Treatment of Obesity

This publication has 55 references indexed in Scilit:

• Discovery of L-755,507: A subnanomolar human β3 adrenergic receptor agonist
  Bioorganic & Medicinal Chemistry Letters, 1998
• Lipolytic effects of conventional β₃‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β₄‐adrenoceptor
  British Journal of Pharmacology, 1997
• Role of the β₃-Adrenoceptor in the Control of Leptin Expression
  Hormone and Metabolic Research, 1996
• Review article: β₃‐adrenoceptor agonists—future anti‐inflammatory drugs for the gastrointestinal tract?
  Alimentary Pharmacology & Therapeutics, 1996
• BMS-187257, a potent, selective, and novel heterocyclic β3 adrenergic receptor agonist
  Bioorganic & Medicinal Chemistry Letters, 1996
• The third beta is not the charm.
  Journal of Clinical Investigation, 1996
• Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist.
  Journal of Clinical Investigation, 1996
• Determination of β₃‐Adrenoceptor Mediated Lipolysis in Human Fat Cells
  Obesity Research, 1995
• Pharmacological characteristics and species‐related variations of β₃‐adrenergic receptors
  Fundamental & Clinical Pharmacology, 1995
• Distribution of β3-adrenoceptor mRNA in human tissues
  European Journal of Pharmacology: Molecular Pharmacology, 1995